Question 1

Does Steward Partners Investment Advisory own XLO stock?

Accepted Answer

No. Steward Partners Investment Advisory exited its XLO (Xilio Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 20,000 shares worth $14,488.

Question 2

How many shares of XLO does Steward Partners Investment Advisory own?

Accepted Answer

None since Q2 2025, when Steward Partners Investment Advisory exited the position. Its Q1 2025 13F listed 20,000 shares worth $14,488.

Question 3

What is Steward Partners Investment Advisory's XLO position worth?

Accepted Answer

Steward Partners Investment Advisory's XLO position was worth $14,488 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Steward Partners Investment Advisory buying or selling XLO?

Accepted Answer

In Q2 2025, Steward Partners Investment Advisory exited its entire XLO position.

Question 5

When did Steward Partners Investment Advisory first buy XLO?

Accepted Answer

Steward Partners Investment Advisory first reported XLO in its Q3 2024 13F and listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$9.52	0
2025-Q1	Unchanged	20,000	0.0%	$14,488	0.0%	$10.14	0
2024-Q4	Unchanged	20,000	0.0%	$19,100	0.0%	$13.37	0
2024-Q3	New	20,000	—	$15,754	0.0%	$11.03	25